دورية أكاديمية

Visual Impairment from Uncorrected Refractive Error among Participants in a Novel Program to Improve Eye Care Access among Low-Income Adults in Michigan.

التفاصيل البيبلوغرافية
العنوان: Visual Impairment from Uncorrected Refractive Error among Participants in a Novel Program to Improve Eye Care Access among Low-Income Adults in Michigan.
المؤلفون: Killeen OJ; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan., Niziol LM; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan., Elam AR; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan., Bicket AK; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan., John D; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan., Wood SD; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan., Musch DC; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan., Zhang J; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan., Johnson L; Hamilton Community Health Network, Flint, Michigan., Kershaw M; Hope Clinic, Ypsilanti, Michigan., Woodward MA; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan., Newman-Casey PA; Department of Ophthalmology and Visual Sciences, University of Michigan, Ann Arbor, Michigan; Institute for Healthcare Policy and Innovation, University of Michigan, Ann Arbor, Michigan. Electronic address: okilleen@med.umich.edu.
المصدر: Ophthalmology [Ophthalmology] 2024 Mar; Vol. 131 (3), pp. 349-359. Date of Electronic Publication: 2023 Sep 26.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7802443 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1549-4713 (Electronic) Linking ISSN: 01616420 NLM ISO Abbreviation: Ophthalmology Subsets: MEDLINE
أسماء مطبوعة: Publication: 2000- : New York : Elsevier
Original Publication: Rochester, Minn., American Academy of Ophthalmology.
مواضيع طبية MeSH: Vision, Low*/complications , Refractive Errors*/epidemiology , Refractive Errors*/therapy, Adult ; Humans ; Male ; Middle Aged ; Female ; Quality of Life ; Michigan/epidemiology ; Cross-Sectional Studies ; Prevalence
مستخلص: Purpose: To assess the rate of visual impairment (VI) from uncorrected refractive error (URE) and associations with demographic and socioeconomic factors among low-income patients presenting to the Michigan Screening and Intervention for Glaucoma and Eye Health through Telemedicine (MI-SIGHT) program.
Design: Cross-sectional study.
Participants: Adults ≥ 18 years without acute ocular symptoms.
Methods: MI-SIGHT program participants received a telemedicine-based eye disease screening and ordered glasses through an online optical store. Participants were categorized based on refractive error (RE) status: VI from URE (presenting visual acuity [PVA], ≤ 20/50; best-corrected visual acuity [BCVA], ≥ 20/40), URE without VI (PVA, ≥ 20/40; ≥ 2-line improvement to BCVA), and no or adequately corrected RE (PVA, ≥ 20/40; < 2-line improvement to BCVA). Patient demographics, self-reported visual function, and satisfaction with glasses obtained through the program were compared among groups using analysis of variance, Kruskal-Wallis, chi-square, and Fisher exact testing.
Main Outcome Measures: PVA, BCVA, and presence of VI (defined as PVA ≤ 20/50).
Results: Of 1171 participants enrolled in the MI-SIGHT program during the first year, average age was 55.1 years (SD = 14.5), 37.7% were male, 54.1% identified as Black, and 1166 (99.6%) had both PVA and BCVA measured. VI was observed in 120 participants (10.3%); 96 had VI from URE (8.2%), 168 participants (14.4%) had URE without VI, and 878 (75.3%) had no or adequately corrected RE. A smaller percentage of participants with VI resulting from URE reported having a college degree, and a larger percentage reported income < $10 000 compared with participants with no or adequately corrected RE (3.2% vs. 14.2% [P = 0.02]; 45.5% vs. 21.6% [P < 0.0001], respectively). Visual function was lowest among participants with VI from URE, followed by those with URE without VI, and then those with no or adequately corrected RE (9-item National Eye Institute Visual Function Questionnaire composite score, 67.3 ± 19.6 vs. 77.0 ± 14.4 vs. 82.2 ± 13.3, respectively; P < 0.0001). In total, 71.2% (n = 830) ordered glasses for an average cost of $36.80 ± $32.60; 97.7% were satisfied with their glasses.
Conclusions: URE was the main cause of VI at 2 clinics serving low-income communities and was associated with reduced vision-related quality of life. An online optical store with lower prices made eyeglasses accessible to low-income patients.
Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
(Copyright © 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.)
References: JAMA. 2006 May 10;295(18):2158-63. (PMID: 16684986)
Am J Prev Med. 2013 Jul;45(1):29-35. (PMID: 23790986)
Ophthalmology. 2013 Sep;120(9):1736-44. (PMID: 23664469)
Arch Ophthalmol. 2008 Aug;126(8):1111-9. (PMID: 18695106)
Am J Ophthalmol. 2023 Jul;251:43-51. (PMID: 36906094)
JMIR Form Res. 2021 Apr 5;5(4):e23233. (PMID: 33739931)
Optom Vis Sci. 2021 Dec 1;98(12):1340-1347. (PMID: 34905522)
EClinicalMedicine. 2021 Apr 26;35:100852. (PMID: 33997744)
Am J Epidemiol. 2010 Mar 15;171(6):728-35. (PMID: 20150357)
Invest Ophthalmol Vis Sci. 2008 Dec;49(12):5264-73. (PMID: 18441303)
Graefes Arch Clin Exp Ophthalmol. 2016 Feb;254(2):395-8. (PMID: 26686513)
Invest Ophthalmol Vis Sci. 2002 Mar;43(3):608-14. (PMID: 11867574)
Ophthalmic Physiol Opt. 2020 May;40(3):249-253. (PMID: 32301126)
J Glaucoma. 2021 May 1;30(5):380-387. (PMID: 33596017)
Front Neurosci. 2022 Jan 27;16:786244. (PMID: 35153667)
Acta Ophthalmol. 2015 Sep;93(6):581-5. (PMID: 25597549)
J Med Internet Res. 2020 Apr 6;22(4):e16951. (PMID: 32250280)
JAMA Intern Med. 2013 Feb 25;173(4):312-3. (PMID: 23338042)
Invest Ophthalmol Vis Sci. 2014 Sep 23;55(10):6996-7005. (PMID: 25249602)
JAMA Ophthalmol. 2022 May 1;140(5):496-502. (PMID: 35420651)
JAMA Ophthalmol. 2016 Jul 1;134(7):802-9. (PMID: 27197072)
J Glaucoma. 2021 May 1;30(5):402-409. (PMID: 33273279)
Lancet Glob Health. 2021 Oct;9(10):e1411-e1422. (PMID: 34411516)
J Am Geriatr Soc. 2019 Feb;67(2):239-245. (PMID: 30421796)
Int J Health Serv. 2012;42(4):607-25. (PMID: 23367796)
JAMA Intern Med. 2020 Oct 1;180(10):1389-1391. (PMID: 32744593)
J Am Med Inform Assoc. 2020 Nov 1;27(11):1816-1818. (PMID: 32589735)
Lancet Glob Health. 2021 Apr;9(4):e418-e430. (PMID: 33607015)
Ophthalmology. 2022 Oct;129(10):e89-e113. (PMID: 36058735)
Optom Vis Sci. 2021 Mar 1;98(3):243-249. (PMID: 33771953)
Arch Ophthalmol. 2004 Apr;122(4):495-505. (PMID: 15078666)
N Engl J Med. 2021 Mar 4;384(9):872-878. (PMID: 33406326)
J AAPOS. 2022 Aug;26(4):185.e1-185.e6. (PMID: 35868623)
Br J Ophthalmol. 2018 Jun 21;:. (PMID: 29930099)
Ophthalmology. 2019 Mar;126(3):338-346. (PMID: 30342076)
JAMA Ophthalmol. 2020 May 1;138(5):479-489. (PMID: 32163124)
JAMA Ophthalmol. 2021 Oct 01;139(10):1104-1114. (PMID: 34499111)
معلومات مُعتمدة: U01 DP006442 United States DP NCCDPHP CDC HHS; U01DP006442 United States ACL ACL HHS
فهرسة مساهمة: Keywords: Eye care delivery; Online optician; Socioeconomic determinants of health; Uncorrected refractive error; Visual impairment
تواريخ الأحداث: Date Created: 20230927 Date Completed: 20240226 Latest Revision: 20240610
رمز التحديث: 20240610
مُعرف محوري في PubMed: PMC10922592
DOI: 10.1016/j.ophtha.2023.09.025
PMID: 37758028
قاعدة البيانات: MEDLINE
الوصف
تدمد:1549-4713
DOI:10.1016/j.ophtha.2023.09.025